Michael Yee
Stock Analyst at Jefferies
(3.12)
# 1,175
Out of 5,128 analysts
106
Total ratings
43.4%
Success rate
14.69%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACLX Arcellx | Assumes: Buy | $100 | $65.01 | +53.82% | 1 | Jan 7, 2026 | |
| IDYA IDEAYA Biosciences | Assumes: Buy | $50 | $37.86 | +32.07% | 1 | Jan 7, 2026 | |
| DNLI Denali Therapeutics | Assumes: Buy | $25 | $16.95 | +47.49% | 3 | Jan 7, 2026 | |
| IMCR Immunocore Holdings | Assumes: Buy | $24 → $55 | $33.76 | +62.91% | 2 | Jan 7, 2026 | |
| IVA Inventiva | Assumes: Buy | $3 → $12 | $5.10 | +135.29% | 1 | Jan 7, 2026 | |
| ANAB AnaptysBio | Assumes: Buy | $20 → $70 | $45.21 | +54.83% | 1 | Jan 7, 2026 | |
| VRDN Viridian Therapeutics | Initiates: Buy | $50 | $30.57 | +63.56% | 1 | Jan 7, 2026 | |
| SRRK Scholar Rock Holding | Initiates: Buy | $60 | $44.23 | +35.65% | 4 | Jan 7, 2026 | |
| VTYX Ventyx Biosciences | Initiates: Buy | $20 | $13.73 | +45.67% | 2 | Jan 7, 2026 | |
| SDGR Schrödinger | Initiates: Neutral | $18 | $18.77 | -4.10% | 3 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $3.97 | +76.32% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $27.81 | +79.79% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $27.07 | +66.24% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $10 | $8.84 | +13.12% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $32.55 | +84.33% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $27.07 | +84.71% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $28 | $28.93 | -3.21% | 3 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $1.49 | +436.91% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $19.03 | +83.92% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $9.65 | +107.25% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $46 → $65 | $56.72 | +14.60% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Neutral | $220 → $240 | $233.42 | +2.82% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $112 → $145 | $124.35 | +16.61% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Neutral | $130 → $185 | $186.91 | -1.02% | 6 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Neutral | $25 | $25.28 | -1.11% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $546 → $535 | $484.15 | +10.50% | 5 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $1,080 → $1,250 | $1,108.09 | +12.81% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $317 → $380 | $341.64 | +11.23% | 6 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 → $3 | $1.18 | +154.24% | 5 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $65 → $55 | $35.89 | +53.25% | 8 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $385 | $620.91 | -37.99% | 4 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $3 | $8.33 | -63.99% | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $60 → $20 | $14.03 | +42.55% | 8 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $1,875 → $1,125 | $9.71 | +11,485.99% | 2 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 → $30 | $3.84 | +681.25% | 4 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $30 | $9.13 | +228.59% | 3 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $120 | $31.39 | +282.29% | 2 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $75.93 | -60.49% | 1 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $77 | $23.14 | +232.76% | 2 | Nov 8, 2018 |
Arcellx
Jan 7, 2026
Assumes: Buy
Price Target: $100
Current: $65.01
Upside: +53.82%
IDEAYA Biosciences
Jan 7, 2026
Assumes: Buy
Price Target: $50
Current: $37.86
Upside: +32.07%
Denali Therapeutics
Jan 7, 2026
Assumes: Buy
Price Target: $25
Current: $16.95
Upside: +47.49%
Immunocore Holdings
Jan 7, 2026
Assumes: Buy
Price Target: $24 → $55
Current: $33.76
Upside: +62.91%
Inventiva
Jan 7, 2026
Assumes: Buy
Price Target: $3 → $12
Current: $5.10
Upside: +135.29%
AnaptysBio
Jan 7, 2026
Assumes: Buy
Price Target: $20 → $70
Current: $45.21
Upside: +54.83%
Viridian Therapeutics
Jan 7, 2026
Initiates: Buy
Price Target: $50
Current: $30.57
Upside: +63.56%
Scholar Rock Holding
Jan 7, 2026
Initiates: Buy
Price Target: $60
Current: $44.23
Upside: +35.65%
Ventyx Biosciences
Jan 7, 2026
Initiates: Buy
Price Target: $20
Current: $13.73
Upside: +45.67%
Schrödinger
Jan 7, 2026
Initiates: Neutral
Price Target: $18
Current: $18.77
Upside: -4.10%
Jan 7, 2026
Initiates: Buy
Price Target: $7
Current: $3.97
Upside: +76.32%
Jan 7, 2026
Initiates: Buy
Price Target: $50
Current: $27.81
Upside: +79.79%
Jan 7, 2026
Initiates: Buy
Price Target: $45
Current: $27.07
Upside: +66.24%
Jan 7, 2026
Initiates: Neutral
Price Target: $10
Current: $8.84
Upside: +13.12%
Jan 7, 2026
Initiates: Buy
Price Target: $60
Current: $32.55
Upside: +84.33%
Jan 7, 2026
Initiates: Buy
Price Target: $50
Current: $27.07
Upside: +84.71%
Jan 7, 2026
Initiates: Neutral
Price Target: $28
Current: $28.93
Upside: -3.21%
Jan 7, 2026
Initiates: Buy
Price Target: $8
Current: $1.49
Upside: +436.91%
Jan 7, 2026
Initiates: Buy
Price Target: $35
Current: $19.03
Upside: +83.92%
Jan 7, 2026
Initiates: Buy
Price Target: $20
Current: $9.65
Upside: +107.25%
Jan 7, 2026
Upgrades: Buy
Price Target: $46 → $65
Current: $56.72
Upside: +14.60%
Jan 7, 2026
Assumes: Neutral
Price Target: $220 → $240
Current: $233.42
Upside: +2.82%
Jan 7, 2026
Assumes: Buy
Price Target: $112 → $145
Current: $124.35
Upside: +16.61%
Jan 7, 2026
Assumes: Neutral
Price Target: $130 → $185
Current: $186.91
Upside: -1.02%
Jan 7, 2026
Assumes: Neutral
Price Target: $25
Current: $25.28
Upside: -1.11%
Jan 7, 2026
Assumes: Buy
Price Target: $546 → $535
Current: $484.15
Upside: +10.50%
Jan 7, 2026
Assumes: Buy
Price Target: $1,080 → $1,250
Current: $1,108.09
Upside: +12.81%
Jan 7, 2026
Assumes: Buy
Price Target: $317 → $380
Current: $341.64
Upside: +11.23%
Mar 6, 2025
Upgrades: Buy
Price Target: $2 → $3
Current: $1.18
Upside: +154.24%
Oct 15, 2024
Maintains: Hold
Price Target: $65 → $55
Current: $35.89
Upside: +53.25%
Jul 17, 2024
Initiates: Buy
Price Target: $385
Current: $620.91
Upside: -37.99%
Mar 15, 2024
Downgrades: Hold
Price Target: $16 → $3
Current: $8.33
Upside: -63.99%
Oct 25, 2023
Downgrades: Hold
Price Target: $60 → $20
Current: $14.03
Upside: +42.55%
Mar 2, 2021
Downgrades: Hold
Price Target: $1,875 → $1,125
Current: $9.71
Upside: +11,485.99%
Feb 12, 2021
Downgrades: Hold
Price Target: $40 → $30
Current: $3.84
Upside: +681.25%
Feb 12, 2021
Upgrades: Buy
Price Target: $15 → $30
Current: $9.13
Upside: +228.59%
Nov 6, 2020
Downgrades: Hold
Price Target: $120
Current: $31.39
Upside: +282.29%
Sep 14, 2020
Initiates: Buy
Price Target: $30
Current: $75.93
Upside: -60.49%
Nov 8, 2018
Assumes: Buy
Price Target: $77
Current: $23.14
Upside: +232.76%